Company intelligence / Profile preview

Biosino Bio-Technology

Beijing, Beijing, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Biosino is a leading Chinese developer and manufacturer of in vitro diagnostic reagents and analyzers with over 120 registered products on the market. Its clinical chemistry reagents are widely used in hospitals across China. The company also produces a prescription drug—Lumbrokinase capsule—for cardio-cerebrovascular disease. It has established international partnerships and exports to more than 40 countries[1][3].

Therapeutic areas: Metabolic DisordersGastroenterologyEndocrinologyNephrologyImmunologyCardiovascular
Modalities: Diagnostic reagentSmall molecule (for Lumbrokinase capsule)Device (analyzers)
Industry: Biotech

Partnerships

Abbott – distribution agreement for clinical chemistry reagents in China since 2011

Beyond the preview

Go deeper on Biosino Bio-Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biosino Bio-Technology.

Explore the full profile